Filings & corporate actions
18 results filed
CSVNext results · Q2 FY27
Expected 28 Oct 2026 – 13 Nov 2026
Estimate: filed 28–44 days after quarter end, last 4 times
Dividend
₹3.50 per share · last 21 Jul 2026
2026
- 30 JulresultsResults · Q1 FY27 · consolidated and standalone+0.3%NSE
- 21 JuldividendDividend · ₹3.50 per share-0.6%
- 14 JulshareholdingShareholding · 30 Jun 20260.0%NSE
- 24 MayresultsResults · Q4 FY26 · standalone-0.4%NSE
- 23 MayresultsResults · Q4 FY26 · consolidated-0.4%NSE
- 16 AprshareholdingShareholding · 31 Mar 2026-0.6%NSE
- 28 JanresultsResults · Q3 FY26 · consolidated and standalone-0.3%NSE
- 20 JanshareholdingShareholding · 31 Dec 2025-3.9%NSE
Reaction to results · all yearsrose on day 0 in 8 of 18 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q1 FY27 | 30 Jul 2026 | +0.3% | +2.4% | -5.1% | 2.3× |
| Q4 FY26 | 23 May 2026 | -0.4% | -1.0% | +6.3% | 1.0× |
| Q3 FY26 | 28 Jan 2026 | -0.3% | -5.5% | +1.9% | 0.8× |
| Q2 FY26 | 13 Nov 2025 | -1.0% | -1.9% | +2.1% | 0.9× |
| Q1 FY26 | 26 Jul 2025 | -1.0% | -3.5% | -3.1% | 0.5× |
| Q4 FY25 | 24 May 2025 | +0.4% | +1.6% | +8.7% | 1.0× |
| Q3 FY25 | 10 Feb 2025 | -1.0% | -6.3% | -9.7% | 1.6× |
| Q2 FY25 | 28 Oct 2024 | -2.0% | +3.4% | +1.8% | 3.4× |
| Q1 FY25 | 13 Aug 2024 | +1.6% | +0.8% | +9.0% | 0.6× |
| Q4 FY24 | 20 May 2024 | -4.7% | -9.0% | -6.9% | 0.6× |
| Q3 FY24 | 25 Jan 2024 | -0.5% | -3.4% | +4.7% | 0.6× |
| Q2 FY24 | 31 Oct 2023 | -6.5% | -11.2% | -5.5% | 3.5× |
| Q1 FY24 | 8 Aug 2023 | -2.1% | -3.5% | -4.1% | 0.5× |
| Q4 FY23 | 15 May 2023 | +5.0% | +5.1% | +9.3% | 3.5× |
| Q3 FY23 | 9 Feb 2023 | +2.2% | +3.2% | -4.5% | 0.6× |
| Q2 FY23 | 6 Nov 2022 | +4.7% | +7.3% | -6.0% | 2.7× |
| Q1 FY23 | 9 Aug 2022 | +12.5% | +22.5% | +26.4% | 17.8× |
| Q4 FY22 | 30 May 2022 | +0.6% | -3.0% | -4.5% | — |
| Average | +0.4% | -0.1% | +1.1% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q1 FY27
CSVRevenue YoY+33.2%
Profit YoY+16.2%
Interest cost YoY+11.6%
Revenue QoQ+2.2%
Profit QoQ-20.0%
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +16.5% | +14.2% | — | — | — | — |
| Profit | +15.8% | +10.5% | — | — | — | — |
Key data
CSVOpen1,269.20
Day range1,235.60 – 1,273.90
52-week range1,084.00 – 1,610.00
From 52w high-23.0%
RSI (14)17.9
ATR (14)42.58
Volume1.23L
Avg volume (20D)1.47L
Rel volume0.83×
Volatility (1Y)22.9%
Turnover₹15.2Cr
SMA 50 / 2001,450.28 / 1,329.49
Delivery percentage
Latest · 6 Oct 202649.9%
20-day avg58.3%
1-year avg58.3%
Percentile (own history)39th
Range7.0–93.2%
Sessions1,092
Over the last 20 sessions RAINBOW settled 58.3% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 58.3%. The latest session ranks higher than 39% of the 1,092 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
IndustryHospital
Performance returns
CSV| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | -2.33% | -9.68% | -13.96% | -12.82% | +7.85% | -8.97% |
Valuation
CSVMarket cap₹12,591 Cr
P/E (TTM)43.4
EPS (TTM)28.58
Shares outstanding10.16Cr
Listed10 May 2022
Ownership
CSVPromoter49.84%
Promoter Δ QoQ0.00 pp
Public49.98%
FII16.03%
DII22.56%
Pledged0.00%
Quarterly results · consolidated
CSV| Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 444.8 | 445.4 | 459.9 | 470.0 |
| YoY chg | +6.5% | +11.9% | +24.3% | +33.2% |
| Net profit (₹ Cr) | 75.6 | 73.9 | 78.2 | 62.5 |
| YoY chg | -4.3% | +7.2% | +38.3% | +16.2% |
| Net margin | 17.0% | 16.6% | 17.0% | 13.3% |
| EPS | 7.41 | 7.14 | 7.59 | 5.97 |
Shareholding over time
CSVBy quarter
30 Jun 2026 · promoter 49.84% · public 49.98%2022-052026-06
- Promoter
- Public and others
- Promoter
- 49.84%
- Public
- 49.98%
- Promoter change
- 0.00 pp
- Filed
- 14 Jul 2026
- FII
- 16.03%
- DII
- 22.56%
- Promoter pledged
- 0.00%
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.
Financials · quarterly statement
CSV₹ crore, as filed
| Q2 FY24 | Q3 FY24 | Q4 FY24A | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25A | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26A | Q1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 332.7 | 336.0 | 341.1 | 330.2 | 417.5 | 398.1 | 370.1 | 352.9 | 444.8 | 445.4 | 459.9 | 470.0 | |
| Other income | 7.8 | 8.6 | 12.8 | 11.9 | 11.3 | 13.3 | 14.5 | 20.0 | 8.2 | 10.5 | 5.1 | 12.7 | |
| Total income | 340.5 | 344.6 | 353.9 | 342.2 | 428.7 | 411.4 | 384.6 | 372.9 | 453.0 | 456.0 | 465.0 | 482.7 | |
| Total expenses | 255.2 | 259.8 | 284.7 | 288.8 | 323.4 | 317.0 | 307.7 | 301.6 | 350.6 | 358.3 | 376.6 | 398.7 | |
| └ Finance costs | 13.3 | 14.3 | 16.8 | 18.2 | 18.1 | 18.1 | 18.1 | 18.1 | 18.8 | 20.2 | 20.5 | 21.2 | |
| └ Depreciation | 26.8 | 27.7 | 32.3 | 34.1 | 34.9 | 35.2 | 34.2 | 34.2 | 35.8 | 39.6 | 40.9 | 42.2 | |
| Profit before tax | 85.3 | 84.8 | 69.2 | 53.4 | 105.4 | 94.3 | 77.0 | 71.4 | 102.4 | 97.7 | 86.8 | 84.0 | |
| Tax expense | 22.1 | 22.2 | 18.1 | 13.6 | 26.3 | 25.4 | 20.4 | 17.6 | 26.7 | 23.8 | 8.6 | 21.4 | |
| Net profit | 63.2 | 62.6 | 51.1 | 39.7 | 79.0 | 68.9 | 56.6 | 53.8 | 75.6 | 73.9 | 78.2 | 62.5 | |
| EPS | 6.20 | 6.12 | 5.02 | 3.89 | 7.77 | 6.76 | 5.55 | 5.27 | 7.41 | 7.14 | 7.59 | 5.97 | |
| Net margin | 18.99% | 18.63% | 14.97% | 12.03% | 18.93% | 17.32% | 15.28% | 15.25% | 17.00% | 16.59% | 17.01% | 13.31% | |
| PBT margin | 25.63% | 25.23% | 20.28% | 16.16% | 25.24% | 23.70% | 20.80% | 20.22% | 23.01% | 21.93% | 18.87% | 17.86% | |
| Tax rate | 25.91% | 26.18% | 26.18% | 25.54% | 25.01% | 26.91% | 26.52% | 24.62% | 26.13% | 24.36% | 9.88% | 25.51% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 30 Jul 2026.
RAINBOW at a glance
- RAINBOW closed at ₹1,239.7 on 6 Oct 2026, -2.33% on the day, -9.0% over one year, 23.0% below its 52-week high of ₹1,610.
- Delivery was 49.9% of traded quantity on 6 Oct 2026, the 39th percentile of its own 1,092 sessions with a reading (20-session average 58.3%, 1-year average 58.3%).
- Market capitalisation is ₹12,591 crore at a trailing P/E of 43.4 (trailing EPS ₹28.58).
- Q1 FY27 results (consolidated, filed 30 Jul 2026): revenue ₹470 crore (+33.2% year on year), net profit ₹63 crore (+16.2%); the price moved +0.3% on the first session after.
- Promoters held 49.84% at 30 Jun 2026, unchanged on the previous filing.
- Q2 FY27 results are expected between 28 Oct 2026 and 13 Nov 2026, going by past filing dates — an estimate, not an announcement.
About
CSVMacro sectorHealthcare
Basic industryHospital
ISININE961O01016
SeriesEQ
Listed10 May 2022
History from10 May 2022
Sessions1,094
Turnover rank#769
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.
More in Healthcare Services
CSV- APOLLOHOSPApollo Hospitals Enterprise Limited7,914.50-0.88%
- MAXHEALTHMax Healthcare Institute Limited902.50-1.58%
- FORTISFortis Healthcare Limited764.00+0.03%
- YATHARTHYatharth Hospital & Trauma Care Services Limited1,058.80+5.56%
- ASTERDMAster DM Quality Care Limited684.70-0.98%
- MANIPALHOSManipal Health Enterprises Limited690.50+3.52%
- LALPATHLABDr. Lal Path Labs Ltd.1,964.20-0.36%
- ARTEMISMEDArtemis Medicare Services Limited318.35-1.77%
- NEPHROPLUSNephrocare Health Services Limited634.55-0.49%
- GKSLGujarat Kidney And Super Speciality Limited193.62+1.72%
- KIMSKrishna Institute of Medical Sciences Limited693.40-1.71%
- NHNarayana Hrudayalaya Ltd.1,723.80+0.08%
All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE